ATE359296T1 - Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie - Google Patents

Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie

Info

Publication number
ATE359296T1
ATE359296T1 AT95916952T AT95916952T ATE359296T1 AT E359296 T1 ATE359296 T1 AT E359296T1 AT 95916952 T AT95916952 T AT 95916952T AT 95916952 T AT95916952 T AT 95916952T AT E359296 T1 ATE359296 T1 AT E359296T1
Authority
AT
Austria
Prior art keywords
der
dust mite
peptides
treatment
modified peptides
Prior art date
Application number
AT95916952T
Other languages
English (en)
Inventor
Xian Chen
Sean Evans
Ze Ev Shaked
Henry M Franzen
Mei-Chang Kuo
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE359296T1 publication Critical patent/ATE359296T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Navigation (AREA)
AT95916952T 1994-04-14 1995-04-12 Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie ATE359296T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22777294A 1994-04-14 1994-04-14

Publications (1)

Publication Number Publication Date
ATE359296T1 true ATE359296T1 (de) 2007-05-15

Family

ID=22854401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916952T ATE359296T1 (de) 1994-04-14 1995-04-12 Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie

Country Status (12)

Country Link
EP (1) EP0755407B1 (de)
JP (1) JPH09512014A (de)
KR (1) KR100379161B1 (de)
AT (1) ATE359296T1 (de)
AU (1) AU717187B2 (de)
CA (1) CA2187329C (de)
DE (1) DE69535460T2 (de)
DK (1) DK0755407T3 (de)
ES (1) ES2285703T3 (de)
NZ (1) NZ284637A (de)
PT (1) PT755407E (de)
WO (1) WO1995028424A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE296444T1 (de) 1996-03-21 2005-06-15 Circassia Ltd Kryptische peptide und verfahren zu ihrer identifizierung
WO1998006861A2 (en) * 1996-08-15 1998-02-19 Agrivax Incorporated Delivery of tolerogenic antigens via edible plants or plant-derived products
AR020102A1 (es) * 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
AT503530A1 (de) * 2006-04-28 2007-11-15 Biomay Ag Polypeptid mit allergenen eigenschaften
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
WO2009022154A2 (en) * 2007-08-15 2009-02-19 Circassia Limited Peptide with multiple epitopes
AU2013203568B2 (en) * 2007-08-15 2016-02-11 Circassia Limited Peptides for desensibilization against allergens
WO2010018384A1 (en) * 2008-08-15 2010-02-18 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
US10059751B2 (en) 2013-12-23 2018-08-28 Alk-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100274321B1 (ko) * 1990-09-11 2000-12-15 스미드 이. 그레이엄 데르마토파고이디즈(집 먼지 진드기)의 알레르기 항원의 클로닝 및 서열결정
HU220462B1 (hu) * 1991-10-16 2002-02-28 Immulogic Pharmaceutical Corp. A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)

Also Published As

Publication number Publication date
WO1995028424A1 (en) 1995-10-26
EP0755407B1 (de) 2007-04-11
DE69535460T2 (de) 2008-01-03
EP0755407A1 (de) 1997-01-29
NZ284637A (en) 1998-09-24
JPH09512014A (ja) 1997-12-02
DK0755407T3 (da) 2007-08-06
AU2286295A (en) 1995-11-10
CA2187329C (en) 2008-07-08
KR100379161B1 (ko) 2003-06-11
KR970702295A (ko) 1997-05-13
CA2187329A1 (en) 1995-10-26
ES2285703T3 (es) 2007-11-16
AU717187B2 (en) 2000-03-16
DE69535460D1 (de) 2007-05-24
PT755407E (pt) 2007-07-20

Similar Documents

Publication Publication Date Title
HUP0003280A1 (hu) Apolipoprotein A-1 agonista peptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
NZ248377A (en) Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
ATE169304T1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
EA199700135A1 (ru) Ингибиторы клеточной адгезии
DE69432984D1 (de) Therapeutische substituierte guanidine
DE50004018D1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
ATE359296T1 (de) Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DE69820053D1 (de) Stör-notokord zur verminderung der symptome / behandlung von arthritis
DE69831257D1 (de) Histogranin peptide und deren analgetische verwendung
HUP0001458A2 (hu) Specifikus hasnyálmirigy lipáz inhibitor hatású peptidek, ezeket tartalmazó gyógyszerkészítmények és diagnosztikai reagensek, valamint ezek alkalmazása
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
DK0811068T3 (da) Humane DNase I varianter
ATE283279T1 (de) Therapeutische inhaltsstoffe
FR2694938B1 (fr) Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
DE69230644T2 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
DE69420574D1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
HUP0000812A2 (hu) Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0755407

Country of ref document: EP